Ordering
Available Variants10 mg
CHA.92079-10mg
Price
€94.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.92079-10mg | €94.80 |
(E) and (Z) isomers (50:50), analytical standard
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C26H29NO2 |
|---|---|
| CAS Number | 68392-35-8 |
| Molecular Weight | 387.51 |
| NACRES | NA.24 |
| UNSPSC Code | 41116107 |
Safety Information Handling visibility
| pictograms |
GHS08
GHS07
  GHS08,GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 + H312 + H332,H315,H319,H361fd |
| pcodes | P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 - P308 + P313 |
| Hazard Classifications | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
4-Hydroxytamoxifen, with the CAS number 68392-35-8, is a metabolite of the anti-estrogen medication tamoxifen. It is primarily formed through the hepatic metabolism of tamoxifen, where it is converted by the enzyme cytochrome P450 2D6. As a result, 4-hydroxytamoxifen exhibits a higher affinity for estrogen receptors compared to its parent compound, thereby contributing to the therapeutic effects of tamoxifen. This metabolite plays a crucial role in the treatment of hormone receptor-positive breast cancer, where it acts as a selective estrogen receptor modulator to inhibit the growth of cancer cells. The formation and activity of 4-hydroxytamoxifen are significant factors in determining the efficacy of tamoxifen therapy, and its levels are often monitored to optimize treatment outcomes in patients.
